TH1701002032A
(en )
2020-05-04
The use of neridronic acid or its salts for the treatment of osteomyelitis.
TH1601006489A
(en )
2020-03-23
Pro-drak of 1,1 '- (1,6-dioxo-1,6-hexendaiyl) bis-D-proline.
TH1501005494A
(en )
2019-09-23
Inhibitors of the kinurenine pathway
TH1601006837A
(en )
2019-11-18
Compounds for the treatment of spinal cord atrophy
TH1701002473A
(en )
2020-03-30
Immune regulating agents
TH1501005024A
(en )
2019-08-26
Pharmaceutical constituents for the treatment of fungal infections.
TH1701005228A
(en )
2021-02-22
Kv1.3 inhibitors and their medical applications
TH1701007724A
(en )
2019-11-11
TH1601003681A
(en )
2020-05-04
Applications of isosazoline compounds in poultry
TH1701006519A
(en )
2021-02-22
A solid form of a compound in which modulated kinase.
TH169430A
(en )
2017-10-19
Pharmaceutical components against chronic bacterial infection.
TH1701003010A
(en )
2020-04-06
Components for the treatment of schizophrenia
TH1701003135A
(en )
2019-08-05
Composition and methods of medium-chain triglyceride for the treatment of epilepsy.
TH1601003241A
(en )
2019-11-18
Use of benzimidazole-proline derivatives
TH1701005229A
(en )
2021-02-22
Kv1.3 inhibitors and their medical applications
TH178624A
(en )
2018-08-09
Plasmids that stimulate immunity
TH1701001069A
(en )
2020-03-23
Tetrahydro-naphthalene derivatives that inhibit MCL-1 protein.
TH175475A
(en )
2018-04-19
Containers for people with swallowing difficulties
TH1801007603A
(en )
2020-06-01
1-Tetrahydropyranil Carbonyl-2,3-Dihydro-1H-Indole Compound for Cancer Treatment
TH181142A
(en )
2018-11-01
Trk-inhibiting compounds
TH1501005539A
(en )
2019-09-09
Heteroeryl compounds and their uses
TH1601005726A
(en )
2020-01-27
New compound imidazobenzothiazole
TH154431S
(en )
2016-07-13
Pet bed
TH1601004396A
(en )
2020-03-23
Heteroaryyl amide that inhibits the aggregation of proteins.
TH1701001072A
(en )
2019-07-29
Indanylurea compounds that inhibit P38 MAP kinase